Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies how well giving temozolomide, bevacizumab, lithium
carbonate, and radiation therapy works in treating patients with newly diagnosed high grade
glioma.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health